Impact of Prediabetes and Type-2 Diabetes on Outcomes in Patients with COVID-19
Open Access
- 16 June 2021
- journal article
- research article
- Published by Wiley in International Journal of Endocrinology
- Vol. 2021, 1-9
Abstract
Introduction. The true impact of prediabetes and type-2 diabetes in patients with COVID-19 remains unknown, with studies thus far providing conflicting evidence. Methods. This is a single-center retrospective observational study involving 843 hospitalized patients with SARS-CoV-2 infection. Primary outcomes, mortality, and mechanical ventilation use were compared among the three groups: control, prediabetes, and type-2 diabetes. Binomial regression analysis was used to determine predictors of mortality and mechanical ventilation requirement. Results. Age was a significant predictor of mortality. On stratifying our patients based on their age, older patients aged 55 years and above had no difference in mortality or mechanical ventilation requirement among the three groups of control, prediabetes, and type-2 diabetes. However, among the younger population aged less than 55 years, patients with type-2 diabetes had significantly higher mortality as compared with patients in control and prediabetes groups (27% vs 12.5% vs 9%, ). Additionally, newly diagnosed type-2 diabetes patients demonstrated lower mortality rate in comparison to previously known type-2 diabetes patients (18% vs 40%, ). Outcomes in the prediabetes group were similar to that in the control group. Admission hyperglycemia was associated with higher mortality regardless of diabetes status. Conclusion. In older patients aged 55 years and above, status of type-2 diabetes does not influence their mortality. However, in younger patients aged less than 55 years, the presence of type-2 diabetes is an important driver of mortality. Newly diagnosed type-2 diabetes, in comparison with previously diagnosed type-2 diabetes, may have better survival. Presence of prediabetes did not affect outcomes in patients with COVID-19 infection.Keywords
This publication has 20 references indexed in Scilit:
- COVID-19 in the Healthy Patient PopulationArteriosclerosis, Thrombosis, and Vascular Biology, 2020
- Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidenceDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reportsDiabetes & Metabolism, 2020
- The Effect of Age on Mortality in Patients With COVID-19: A Meta-Analysis With 611,583 SubjectsJournal of the American Medical Directors Association, 2020
- Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regressionDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-AnalysisResearch, 2020
- Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective studyEpidemiology and Infection, 2018
- Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARSDiabetic Medicine, 2006